PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,272,173 | -58.1% | 152,356 | -33.2% | 0.01% | -54.2% |
| Q2 2023 | $3,033,610 | -0.5% | 228,091 | -13.4% | 0.02% | -7.7% |
| Q1 2023 | $3,049,987 | +32.6% | 263,384 | -6.4% | 0.03% | +30.0% |
| Q4 2022 | $2,301,001 | +25.0% | 281,296 | -11.2% | 0.02% | +17.6% |
| Q3 2022 | $1,841,000 | +28.5% | 316,847 | -2.3% | 0.02% | +54.5% |
| Q2 2022 | $1,433,000 | -65.0% | 324,376 | -27.9% | 0.01% | -56.0% |
| Q1 2022 | $4,096,000 | -52.2% | 450,108 | +7.5% | 0.02% | -44.4% |
| Q4 2021 | $8,568,000 | -0.7% | 418,778 | +24.0% | 0.04% | -13.5% |
| Q3 2021 | $8,626,000 | +3803.2% | 337,642 | +5231.5% | 0.05% | +5100.0% |
| Q2 2021 | $221,000 | +202.7% | 6,333 | -55.0% | 0.00% | 0.0% |
| Q3 2019 | $73,000 | -62.4% | 14,080 | -56.0% | 0.00% | -50.0% |
| Q2 2019 | $194,000 | -16.0% | 32,023 | +0.4% | 0.00% | 0.0% |
| Q1 2019 | $231,000 | – | 31,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |